EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug

Liliana Dell'Osso, Chiara Bonelli, Benedetta Nardi iD, Federico Giovannoni, Cristiana Pronestì, Ivan Mirko Cremone, Giulia Amatori, Stefano Pini iD, Barbara Carpita

Brain Sciences · 20.01.2024 · 14 (1) · 103

DOI: 10.3390/brainsci14010103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 20.01.2024. Verfasst von Liliana Dell'Osso und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, 67 Via Roma, 56126 Pisa, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current literature globally highlights the efficacy of Clozapine in several psychiatric disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal behavior in patients with schizophrenia or schizoaffective disorder. A growing field of research is also stressing a possible broader beneficial effect of Clozapine in promoting neuroprotection and neurotrophism. However, this drug is linked to several life-threatening side effects, such as agranulocytosis, myocarditis and seizures, that limit its use in daily clinical practice. For this work, a search was performed on PubMed using the terms “Clozapine indications”, “Clozapine adverse effects”, “Clozapine regenerative effects”, and “Clozapine neuroplasticity” with the aim of reviewing the scientific literature on Clozapine’s treatment indications, adverse effects and potential regenerative role. The results confirmed the efficacy of clozapine in clinical practice, although limited by its adverse effects. It appears crucial to raise awareness among clinicians about the potential benefits of using Clozapine, as well educating medical personnel about its risks and the early identification of possible adverse effects and their management.

Schlagwörter

Stichwörter der Autor:innen

Clozapineadverse effectsregenerative effectstreatment indications

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, 67 Via Roma, 56126 Pisa, Italy.

ORCID-Profile: Benedetta Nardi, Stefano Pini

Zitieren

APA

Dell'Osso, L., Bonelli, C., Nardi, B., Giovannoni, F., Pronestì, C., Cremone, I. M., Amatori, G., Pini, S., & Carpita, B. (2024). Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. Brain Sciences, 14(1), 103. https://doi.org/10.3390/brainsci14010103

Vancouver

Dell'Osso L, Bonelli C, Nardi B, Giovannoni F, Pronestì C, Cremone IM, et al. Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. Brain Sciences. 2024;14(1):103. doi:10.3390/brainsci14010103

BibTeX
@article{DellOsso2024,
  author = {Dell'Osso, Liliana and Bonelli, Chiara and Nardi, Benedetta and Giovannoni, Federico and Pronestì, Cristiana and Cremone, Ivan Mirko and Amatori, Giulia and Pini, Stefano and Carpita, Barbara},
  title = {Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug},
  journal = {Brain Sciences},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {103},
  doi = {10.3390/brainsci14010103}
}
Kostenlos starten →